An Open Label Single Oral Dose Study
  • Description A forum to discuss or ask questions about an Open Label Single Oral Dose Study in Patients with Mild Alzheimer's Disease to Assess the Pharmacokinetics of Extended-Release Formulation of Rosiglitazone (RSG XR) in This Population
  • Threads 1 Discussion
Frequently Asked